Coronavirus
CDC urges mpox vaccination among people at high risk to prevent summer surge
Bottle of Vaccine for booster shot for Smallpox and Monkeypox MPXV. Angelp | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday urged gay men and other individuals at high risk from mpox to get fully vaccinated to prevent a summer resurgence of the virus. The CDC’s call for those at […]
Read More
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health
A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022. Johanna Geron | Reuters Patients are now enrolling in an early stage clinical trial to test a universal flu vaccine based on messenger RNA technology, the National Institutes of Health announced Monday. […]
Read More
Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Uninsured Americans can still access Covid-19 vaccines at no cost, for now, even though the U.S. public health emergency has […]
Read More
U.S. Covid public health emergency ends, leaving behind a battered health system
A sign outside of a hospital advertises COVID-19 testing on November 19, 2021 in New York City. Spencer Platt | Getty Images The U.S. public health emergency declared in response to Covid-19 comes to an end Thursday more than three years after the pandemic began. The Biden administration’s decision to end the emergency comes as […]
Read More
CDC Director Rochelle Walensky will resign in June
Director of the Centers for Disease Control Rochelle Walensky departs after testifying before the Senate Committee on Health, Education, Labor and Pensions on the All-Hazards Preparedness Act at the Dirksen Senate Office Building on Thursday, May 4, 2023 in Washington, DC. Kent Nishimura | Los Angeles Times | Getty Images CDC Director Dr. Rochelle Walensky […]
Read More
CDC will have less data to track Covid and new variants after public health emergency ends
People walk by a Covid-19 testing site at Times Square on May 12, 2022 in New York City. Liao Pan | China News Service | Getty Images The Centers for Disease Control and Prevention will have less data to track the spread of Covid-19 and new variants in the U.S. after the public health emergency […]
Read More
WHO declares end to Covid global public health emergency
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), speaks during a news conference in Geneva, Switzerland, December 20, 2021. Denis Balibouse | Reuters The spread of Covid-19 is no longer a global public health emergency, the World Health Organization declared on Friday. “For more than a year, the pandemic has been on a […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
CVS beats on earnings and revenue but lowers profit outlook
A CVS location in New York, US, on Thursday, Feb. 9, 2023. Stephanie Keith | Bloomberg | Getty Images CVS Health on Thursday reported first-quarter results that beat earnings and revenue expectations, but the company lowered its full-year profit guidance due to costs related to recent acquisitions. Shares fell more than 1% in premarket trading […]
Read More